60,053 Corteva, Inc. $CTVA Shares Acquired by Keybank National Association OH

Keybank National Association OH lifted its stake in Corteva, Inc. (NYSE:CTVA) by 94.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 123,914 shares of the company’s stock after acquiring an additional 60,053 shares during the quarter. Keybank National Association OH’s holdings in Corteva were worth $9,622,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the stock. Parkside Financial Bank & Trust raised its position in Corteva by 3.2% in the second quarter. Parkside Financial Bank & Trust now owns 3,729 shares of the company’s stock valued at $316,000 after purchasing an additional 116 shares during the period. HB Wealth Management LLC lifted its stake in Corteva by 0.5% during the second quarter. HB Wealth Management LLC now owns 23,822 shares of the company’s stock worth $2,018,000 after purchasing an additional 128 shares in the last quarter. Wilkerson Advisory Group LLC boosted its position in shares of Corteva by 6.7% during the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after buying an additional 133 shares during the period. Aviance Capital Partners LLC boosted its position in shares of Corteva by 1.3% during the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock worth $922,000 after buying an additional 137 shares during the period. Finally, Pinnacle Wealth Management Advisory Group LLC grew its stake in shares of Corteva by 3.2% in the second quarter. Pinnacle Wealth Management Advisory Group LLC now owns 4,762 shares of the company’s stock valued at $403,000 after buying an additional 147 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Trending Headlines about Corteva

Investors following CTVA have been watching these headlines:

• Positive Sentiment: Corteva said new-product sales growth and operational execution helped cushion market headwinds. One report also showed adjusted Q3 EPS of $0.06, above the $0.02 consensus estimate, though coverage described the overall quarter as weak and results varied by measure. Corteva Q3 results and outlook
• Neutral Sentiment: Investors bought 2,661 call options, about 149% above the average volume. This signals increased trading activity but does not establish a clear direction for the shares.
• Negative Sentiment: Corteva lowered its 2026 EPS guidance to $0.76–$0.80, below the roughly $1.07 analyst consensus. The company cited weaker-than-expected conditions in Brazil, where the CEO warned the slump could continue. Reuters report on Brazil weakness and forecast cut

Wall Street Analyst Weigh In

CTVA has been the topic of several research analyst reports. Bank of America boosted their price objective on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Zacks Research lowered Corteva from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 6th. UBS Group lowered their target price on Corteva to $15.00 and set a “neutral” rating for the company in a report on Monday, October 12th. Deutsche Bank reaffirmed a “buy” rating and issued a $101.00 target price on shares of Corteva in a research report on Monday, August 3rd. Finally, Citigroup boosted their price target on shares of Corteva from $86.00 to $91.00 and gave the stock a “neutral” rating in a research note on Thursday, September 17th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and an average price target of $56.91.

Corteva Price Performance

CTVA stock opened at $9.26 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The firm has a market capitalization of $6.18 billion, a P/E ratio of 3.20, a P/E/G ratio of 1.69 and a beta of 0.58. The business’s 50-day moving average is $38.81 and its two-hundred day moving average is $69.88. Corteva, Inc. has a 1 year low of $9.14 and a 1 year high of $90.97.

Corteva Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Tuesday, December 1st will be given a dividend of $0.05 per share. This is a drop from Corteva’s previous quarterly dividend of $0.18. This represents a $0.20 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, December 1st. Corteva’s dividend payout ratio is presently 47.68%.

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.